You are here

antitrust

J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest

J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest

Endpoints

Flag link:

In Pfizer-Seagen review, FTC has chance to set new pharma precedent

In Pfizer-Seagen review, FTC has chance to set new pharma precedent

BioPharma Dive

anticompetitive practices

Flag link:

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

Fierce Pharma

Flag link:

Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table

Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table

Fierce Pharma

Gilead Sciences

Teva Pharmaceutical

Flag link:

Novartis, Roche avoid $475M antitrust fine in French appeals court

Novartis, Roche avoid $475M antitrust fine in French appeals court

Fierce Pharma

Flag link:

Illumina Could Face Hefty Fine Over Grail Acquisition

Illumina Could Face Hefty Fine Over Grail Acquisition

Medical Devices and Diagnostics Industry

Flag link:

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Flag link:

Is CVS' Acquisition of Signify in Danger of Falling Through?

Is CVS' Acquisition of Signify in Danger of Falling Through?

Motley Fool

Flag link:

Illumina defeats F.T.C. in major antitrust case

Illumina defeats F.T.C. in major antitrust case

NY Times, NY

Flag link:

After delay, CSL's $11.7B deal for Vifor poised to close next week

After delay, CSL's $11.7B deal for Vifor poised to close next week

Fierce Pharma

Flag link:

Can Illumina Hold on to Grail?

Can Illumina Hold on to Grail?

Medical Devices and Diagnostics Industry

Flag link:

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Fierce Pharma

Flag link:

Illumina loses challenge to block EU antitrust probe into $8B Grail buyout

Illumina loses challenge to block EU antitrust probe into $8B Grail buyout

Endpoints

Flag link:

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Fierce Pharma

Flag link:

As antitrust case wraps, Martin Shkreli's lawyers say they're owed $2M+ in unpaid legal fees

As antitrust case wraps, Martin Shkreli's lawyers say they're owed $2M+ in unpaid legal fees

Endpoints

Flag link:

AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger

AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger

Fierce Pharma

Flag link:

Antitrust regulators aim to revamp merger guidelines, signaling threat to health sector deals

Antitrust regulators aim to revamp merger guidelines, signaling threat to health sector deals

BioPharma Dive

Flag link:

Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case

Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case

Fierce Pharma

Flag link:

Shkreli's former company Vyera settles for $40M in antitrust case, but 'pharma bro' still faces his own trial

Shkreli's former company Vyera settles for $40M in antitrust case, but 'pharma bro' still faces his own trial

Fierce Pharma

Vyera Pharmaceuticals

Flag link:

Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January

Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January

Fierce Pharma

Flag link:

Pages